中国组织工程研究 ›› 2010, Vol. 14 ›› Issue (25): 4721-4724.doi: 10.3969/j.issn.1673-8225.2010.25.040

• 生物材料学术探讨 biomaterial academic discussion • 上一篇    下一篇

血管支架材料表面改性与血管内膜的增生

刘章起,李春亮   

  1. 河北北方学院,河北省张家口市  075000
  • 出版日期:2010-06-18 发布日期:2010-06-18
  • 作者简介:刘章起,男,1965年生,河北省故城县人,汉族,1985年张家口医学院毕业,主治医师,主要从事心血管内科方面的研究。 nzlzqlzq@163.com

Effect of intravascular stent surface modification on tunica intimal hyperplasia

Liu Zhang-qi, Li Chun-liang   

  1. Hebei North University, Zhangjiakou   075000, Hebei Province, China
  • Online:2010-06-18 Published:2010-06-18
  • About author:Liu Zhang-qi, Attending physician, Hebei North University, Zhangjiakou 075000, Hebei Province, China nzlzqlzq@163.com

摘要:

目的:评价血管材料改性后对血管内皮增生的影响和应用前景。
方法:以“血管支架材料,表面改性,内皮增生,再狭窄,生物相容性”为中文关键词,以“biological vascular scaffold;surface modification; tunica intimal hyperplasia;restenosis;biocompatibility” 为英文关键词,采用计算机检索2008-01/2010-04相关文章。纳入有关与血管支架材料,血管支架材料改性相关的文章,排除重复研究或Meta分析类文章,以30篇为重点分析,讨论血管支架材料改性对血管内皮增生、再狭窄的影响。
结果:支架植入后血管内膜的增生和再狭窄严重影响了其远期疗效,大量的动物实验和临床分析表明,血管支架材料表面改性及载药复合支架能比裸体支架能更有效解决局部慢性炎症反应、内皮功能障碍、抗凝血等问题,显示出良好的安全性和降低冠状动脉再狭窄的有效性。可降解血管组织工程支架的发展将成为新的里程碑,内皮细胞是血管组织工程中最重要的种子细胞,通过种子细胞在体外种植于生物可吸收材料的血管支架上,达到修复创伤、病变和重建功能的目的。
结论:血管支架材料表面改性是目前解决支架植入后抑制内膜增生,防止血栓形成和再狭窄等问题有效方法之一。血管组织工程支架发展前景广阔。

关键词: 血管支架材料, 表面改性, 内皮增生, 再狭窄, 生物相容性

Abstract:

OBJECTIVE: To evaluate the influence of modified vascular stent materials on tunica intimal hyperplasia and their applications.
METHODS: By using “vascular stents, surface modification, intimal hyperplasia, restenosis, biocompatibility” in Chinese and “biological vascular scaffold, surface modification, tunica intimal hyperplasia, restenosis, biocompatibility” in English as the keywords, a computer search was performed among articles published from January 2008 to April 2010. Articles related to the vascular stent materials and their modification were included, while duplicated research or Meta analysis were excluded. Thirty articles focus on the influence of stent material modification on the tunica intimal hyperplasia and restenosis.
RESULTS: After stenting, the tunica intimal hyperplasia and restenosis have serious impact on its long-term effect. A large number of animal experiments and clinical analysis showed that the stent surface modification and carrying drug composite stent can be more effective than the naked stents to solve local chronic inflammation, endothelial dysfunction and anti-coagulation problems, showing good safety and effectiveness in reducing the coronary artery restenosis. The development of biodegradable vascular tissue-engineered stents will become a new milestone. Vascular endothelial cells are the most crucial seed cells of vascular tissue engineering. Seed cells were implanted on the bio-absorbable stent materials in vitro, hopefully to repair traumatic lesions and reconstruct functions.
CONCLUSION: The vascular stent surface modification is one of the effective methods for inhibiting intimal hyperplasia, preventing thrombosis and restenosis after stent implantation. Vascular tissue-engineered stents have broad development prospects.

中图分类号: